Incyte Corporation (INCY) is a Wilmington, Delaware-based biopharmaceutical company founded in 2002 that discovers, develops, and commercializes proprietary medicines for oncology, inflammation, autoimmunity, and dermatology; it operates gl…
HQ: Wilmington, DE, United States of Americawww.incyte.com
USD120.97-0.60%vs prev. close
Performance
1W
+1.10%
1M
+8.43%
3M
+0.67%
1Y
+14.76%
YTD
+22.48%
Valuation
P/E
62.0
EPS TTM
1.95
Dividend yield
—
Size and risk
Market cap
$24.7B
Beta
0.78
Price history
INCY price
USD
Total returnEventsVs index
Loading…
Next earnings
Report date
EPS estimate
Revenue estimate
Peer comparison
Incyte
INCY
Biotechnology
Mkt cap (USD bn)
24.7
P/E
62.0
Div yld
—
1W
+1.1%
1M
+8.4%
3M
+0.7%
6M
+26.9%
1Y
+14.8%
YTD
+22.5%
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Incyte
INCY
Biotechnology
24.7
62.0
—
+1.1%
+8.4%
+0.7%
+26.9%
+14.8%
+22.5%
Subscribe to Equity Analytics to compare INCY with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.